ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SHPH Shuttle Pharmaceuticals Holdings Inc

0.389
0.001 (0.26%)
After Hours
Last Updated: 17:10:43
Delayed by 15 minutes

Period:

Draw Mode:

Volume 17,912
Bid Price 0.3764
Ask Price 0.39
News -
Day High 0.4299

Low
0.35

52 Week Range

High
2.75

Day Low 0.371
Company Name Stock Ticker Symbol Market Type
Shuttle Pharmaceuticals Holdings Inc SHPH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.001 0.26% 0.389 17:10:43
Open Price Low Price High Price Close Price Prev Close
0.371 0.371 0.4299 0.389 0.388
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
73 17,912 $ 0.3857712 $ 6,910 - 0.35 - 2.75
Last Trade Time Type Quantity Stock Price Currency
16:59:55 1 $ 0.3763 USD

Shuttle Pharmaceuticals Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
6.24M 16.00M - 0 -6.59M -0.41 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Shuttle Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SHPH Message Board. Create One! See More Posts on SHPH Message Board See More Message Board Posts

Historical SHPH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.4150010.42990.37050.3947413,770-0.026-6.27%
1 Month0.440.440.37050.416370437,225-0.051-11.59%
3 Months0.42390.5450.350.412533952,856-0.0349-8.23%
6 Months0.540.61830.350.4668273110,647-0.151-27.96%
1 Year1.422.750.351.26460,494-1.03-72.61%
3 Years24.05126.260.357.56856,720-23.66-98.38%
5 Years24.05126.260.357.56856,720-23.66-98.38%

Shuttle Pharmaceuticals Description

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.

Your Recent History

Delayed Upgrade Clock